Literature DB >> 64663

Biochemical markers in human breast cancer.

R C Coombes, T J Powles, J C Gazet, H T Ford, J P Sloane, D J Laurence, A M Neville.   

Abstract

Nineteen biochemical parameters, most of which have been individually advocated as tumour-index-substances for breast cancer, were measured in 51 patients with breast disease, 42 of whom had active breast cancer. Seven of these parameters were raised in more than half of the 17 patients of the series with overt metastases; these were serum ferritin (88%), C-reactive protein (87%), carcinoembryonic antigen (81%), acid glycoprotein (75%), total alkaline phosphatase (64%), sialyl transferase (56%), andthe urinary hydroxyproline/creatinine ratio (73%). The incidence of biochemical abnormalities in patients in this group compared favourably with the results of physical methods of detecting metastases. 7 of 16 further patients without evidence of distant metastases, but who had a poor prognosis as judged by histology of the primary tumour and axillary lymph-nodes, had abnormalities of at least one of the seven parameters. 3 of these patients have relapsed within a year of mastectomy. The results suggest that these biochemical tests could assist in monitoring metastatic disease and could indicate at the time of mastectomy, patients who might benefit from immediate systemic therapy in addition to local treatment of their breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 64663     DOI: 10.1016/s0140-6736(77)91719-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Monocyte maturation and prognosis in primary breast cancer.

Authors:  S A Taylor; G A Currie
Journal:  Br Med J       Date:  1979-04-21

2.  Tumour markers in breast cancer.

Authors: 
Journal:  Br Med J       Date:  1979-04-21

3.  A traction force threshold signifies metastatic phenotypic change in multicellular epithelia.

Authors:  Yao Zhang; Xuechen Shi; Tiankai Zhao; Changjin Huang; Qiong Wei; Xin Tang; Lorraine C Santy; M Taher A Saif; Sulin Zhang
Journal:  Soft Matter       Date:  2019-09-18       Impact factor: 3.679

4.  Evaluation of biochemical markers in breast cancer.

Authors:  R C Coombes; T J Powles; A M Neville
Journal:  Proc R Soc Med       Date:  1977-12

5.  C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis.

Authors:  P Puolakkainen; V Valtonen; A Paananen; T Schröder
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

6.  Physical test for distant metastases in patients with breast cancer.

Authors:  R C Coombes; T J Powles; M Abbott; L De Rivas; H T Ford; V R McCready; A M Neville; J C Gazet
Journal:  J R Soc Med       Date:  1980-09       Impact factor: 5.344

Review 7.  Serum ferritin and malignant tumours.

Authors:  A Jacobs
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Tests for detecting recurrent disease in the follow-up of patients with breast cancer.

Authors:  J L Mansi; H M Earl; T J Powles; R C Coombes
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

9.  Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication.

Authors:  Michael I Koukourakis; Georgia Kambouromiti; Dimitra Pitsiava; Pelagia Tsousou; Maria Tsiarkatsi; George Kartalis
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

10.  Prospective assessment of the role of five tumour markers in breast cancer.

Authors:  J F Robertson; D Pearson; M R Price; C Selby; J Pearson; R W Blamey; A Howell
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.